Treace Medical director granted 30,000 RSUs
Jain Deepti reported acquisition or exercise transactions in this Form 4 filing.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Jain Deepti reported acquisition or exercise transactions in this Form 4 filing.
Treace Medical Concepts director Deepti Jain reported receiving a grant of 30,000 restricted stock units (RSUs) of common stock at no purchase price. These RSUs will vest 100% on the earlier of May 19, 2027 or the 2027 annual meeting of stockholders, conditioned on continued service. Following this award, Jain holds 100,243 shares in total, including the 30,000 RSUs.
Insider Trade Summary
Grant/Award: 30,000 shares
Grant/Award
1 txn
Insider
Jain Deepti
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 30,000 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 100,243 shares (Direct)
Holdings Before and After:
Common Stock, 70,243 to 100,243 shares (Direct)
Footnotes (2)
- F1. Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 19, 2027 or (b) the date of the 2027 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date.
- F2. Includes 30,000 restricted stock units.
Key Figures
RSU grant size: 30,000 RSUs
Transaction price: $0.0000 per share
Post-transaction holdings: 100,243 shares
+2 more
5 metrics
RSU grant size
30,000 RSUs
Restricted stock units granted on May 19, 2026
Transaction price
$0.0000 per share
Reported price per share for RSU grant
Post-transaction holdings
100,243 shares
Total common stock holdings after RSU award
Vesting date
Earlier of May 19, 2027 or 2027 annual meeting
RSUs vest 100% on earliest of these dates
RSUs included in total
30,000 RSUs
Footnote states total holdings include these RSUs
Key Terms
restricted stock units (RSUs), vesting, annual meeting of stockholders
3 terms
restricted stock units (RSUs) financial
"Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share"
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
vesting financial
"receive one (1) share of Issuer's Common Stock for each RSU upon vesting."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
annual meeting of stockholders financial
"on the earlier of (a) May 19, 2027 or (b) the date of the 2027 annual meeting of stockholders"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Treace Medical Concepts (TMCI) director Deepti Jain report in this Form 4?
Director Deepti Jain reported receiving a grant of 30,000 restricted stock units (RSUs) of Treace Medical Concepts common stock. The award was reported as an acquisition at no purchase price and increased her total reported holdings to 100,243 shares, including these RSUs.
How many Treace Medical Concepts (TMCI) RSUs were granted to Deepti Jain?
Deepti Jain was granted 30,000 restricted stock units (RSUs) of Treace Medical Concepts common stock. Each RSU entitles her to receive one share of common stock upon vesting, subject to the vesting schedule and continued service requirements described in the filing’s footnotes.
When will Deepti Jain’s 30,000 Treace Medical (TMCI) RSUs vest?
The 30,000 RSUs will be 100% vested on the earlier of May 19, 2027 or the date of Treace Medical Concepts’ 2027 annual meeting of stockholders. Vesting is conditioned on Jain continuing to provide service to the company through the applicable vesting date.
What are Deepti Jain’s total Treace Medical (TMCI) holdings after this RSU grant?
After the reported RSU grant, Deepti Jain’s total holdings are 100,243 shares of Treace Medical Concepts common stock. This total explicitly includes the 30,000 restricted stock units disclosed in the footnotes, which each convert into one share upon vesting, subject to conditions.
Does Deepti Jain pay a purchase price for the Treace Medical (TMCI) RSUs?
The Form 4 shows a transaction price per share of 0.0000 for the 30,000 RSUs, indicating no cash purchase price. Instead, these RSUs are a compensation-related grant that converts into common shares upon vesting, assuming continued service to Treace Medical Concepts.
AI-generated analysis. How Rhea-AI works. Not financial advice.
